FEATURED EDITORIAL
After graduating with a biology degree from Howard University and entering the pharma industry, Stephanie Wimberly found herself the only woman — the only black woman — in a manufacturing facility in Maryland. A supervisor made it clear he didn’t want her on his team; she was reassigned to the night shift at her facility. “I had a family to support, and night shift, or abuse, was not what I signed up for,” she says. “But I didn’t have many options.” Here is how she persevered, and prospered.
- A Biotech Business Model That's Investor-Friendly
- The Supreme Court Rules On Trump Tariffs. Why Shout "Hooray!"?
- Dynamic Flux Analysis Offers Faster Metabolic Modeling Than DOE
- Six Specialized Modalities Testing CDMO Readiness In 2026
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Real Reason We Haven't Fully Automated Cell Therapy Yet
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
GUEST COLUMNISTS
-
Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
Effective sustainability strategies in pharma supply chains reduce rework and overage. Three leakage points offer the most practical starting point for rooting out waste.
-
The Real Reason We Haven't Fully Automated Cell Therapy Yet
Manual cell therapy workflows often set the tone for automation. This discussion suggests the approach is flawed and presents automation as a chance to innovate.
-
The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
Clinical trial supply chains are evolving: digital twins, on-demand kits, and sustainable logistics replace reactive firefighting with precision, speed, and resilience.
-
The Hidden Engineering Behind Successful Upstream Bioprocessing
In upstream biopharmaceutical production, manufacturing is inseparable from biology, engineering, contamination control, and quality science.
-
A Practical Look At Modern Downstream Processing For Biologics
Part 2 in a series about current bioprocessing practices explores the latest in separation, purification, sterile filtration and aseptic filling.
-
Process Engineering's Key Role In Sterile Injectable Facility Design
Quality requirements for parenteral drugs complicate facility design like few other regulated products. If you're developing injectables, be aware of these key issues.
-
What To Know About — And How To Apply For — FDA's PreCheck Pilot
FDA has now provided specific eligibility and selection criteria for the PreCheck Pilot Program and a timeline for next steps.
-
MES Is Still In The CD ROM Era But The Data Architecture Has Moved On
Many manufacturing execution system (MES) deployments still operate like it is 2005: a big install, disruptive upgrades, etc. Here's a clearer path forward.
PHARMA OUTSOURCING WHITE PAPERS
-
Modern Lentiviral Platforms For Scalable Cell Therapy
A new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.
-
Advancing A LNP Formulation To Clinical And Commercial Manufacturing
Lipid selection impacts the final LNP drug product and the LNP process. Review critical quality considerations for lipids and the process requirements for successful commercial-scale manufacturing.
-
Solve ATMP Aseptic Filling Challenges With Gloveless Isolators
Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.
-
Stopper Migration In Frozen Pre-Filled Syringes
Review a semi-automated method for dynamically assessing plunger migration under controlled variations in temperature and pressure, utilizing computer vision tools.
-
Mitigating Nitrosamine Risks In Pharmaceuticals
Nitrosamines can come from a range of sources, including raw materials, manufacturing processes, and even water sources. Detecting them requires sensitive analytical methods.
-
Placing Drug Strategies On A Solid Foundation For Success
Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.
PHARMA OUTSOURCING APP NOTES & CASE STUDIES
- Enhancing Viral Clearance Prediction And Process Optimization
- Streamlining Analytical Release Testing With Faster, Smaller Workflows
- Cell Retention Technology And Specialized Cell Culture Media
- Cell Culture Media Filtration: Evaluating Cell Culture Performance
- Mitigating Powder Flow And Static Issues Using SYLOID® Mesoporous Silica
NEWSLETTER ARCHIVE
- 03.06.26 -- New Podcast Episodes: Therapeutic Power Of Fibroblasts, Curative Cell Therapies, Breakthrough HER2 Immunotherapy
- 03.06.26 -- The Supreme Court Rules On Trump Tariffs. Why Shout "Hooray!"?
- 03.05.26 -- Advancing Fill‑Finish, Bioconjugation, And Sterile Manufacturing Innovation
- 03.05.26 -- The Supreme Court Rules On Trump Tariffs. Why Did You Shout "Hooray!"?
REPORTING
PRODUCTS & SERVICES
ON-DEMAND WEBINARS
- From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development
- Strategies For Robust Process Characterization And Validation To Accelerate Biologics Manufacturing
- Translating Stem Cell Programs To GMP
- Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies
- USP <665> Compliance Guidance